Medpace Holdings, Inc. (MEDP)
Total Valuation
MEDP has a market cap or net worth of $12.48 billion. The enterprise value is $12.38 billion.
Market Cap | 12.48B |
Enterprise Value | 12.38B |
Important Dates
The next confirmed earnings date is Monday, April 22, 2024, after market close.
Earnings Date | Apr 22, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MEDP has 30.76 million shares outstanding. The number of shares has decreased by -5.43% in one year.
Shares Outstanding | 30.76M |
Shares Change (YoY) | -5.43% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | 18.26% |
Owned by Institutions (%) | 83.67% |
Float | 25.11M |
Valuation Ratios
The trailing PE ratio is 45.51 and the forward PE ratio is 37.36. MEDP's PEG ratio is 2.75.
PE Ratio | 45.51 |
Forward PE | 37.36 |
PS Ratio | 6.62 |
Forward PS | 5.59 |
PB Ratio | 22.33 |
P/FCF Ratio | 31.46 |
PEG Ratio | 2.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.39, with an EV/FCF ratio of 31.20.
EV / Earnings | 43.76 |
EV / Sales | 6.56 |
EV / EBITDA | 32.39 |
EV / EBIT | 36.81 |
EV / FCF | 31.20 |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.25.
Current Ratio | 0.64 |
Quick Ratio | 0.59 |
Debt / Equity | 0.25 |
Debt / EBITDA | 0.37 |
Debt / FCF | 0.36 |
Interest Coverage | 688.87 |
Financial Efficiency
Return on equity (ROE) is 64.00% and return on invested capital (ROIC) is 40.48%.
Return on Equity (ROE) | 64.00% |
Return on Assets (ROA) | 19.00% |
Return on Capital (ROIC) | 40.48% |
Revenue Per Employee | $319,634 |
Profits Per Employee | $47,934 |
Employee Count | 5,900 |
Asset Turnover | 1.27 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $52.87 million in taxes.
Income Tax | 52.87M |
Effective Tax Rate | 15.75% |
Stock Price Statistics
The stock price has increased by +122.65% in the last 52 weeks. The beta is 1.38, so MEDP's price volatility has been higher than the market average.
Beta (1Y) | 1.38 |
52-Week Price Change | +122.65% |
50-Day Moving Average | 364.45 |
200-Day Moving Average | 287.46 |
Relative Strength Index (RSI) | 59.87 |
Average Volume (30 Days) | 251,478 |
Short Selling Information
The latest short interest is 963,637, so 3.13% of the outstanding shares have been sold short.
Short Interest | 963,637 |
Short Previous Month | 937,214 |
Short % of Shares Out | 3.13% |
Short % of Float | 3.84% |
Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, MEDP had revenue of $1.89 billion and earned $282.81 million in profits. Earnings per share was $8.88.
Revenue | 1.89B |
Gross Profit | 524.51M |
Operating Income | 336.83M |
Pretax Income | 335.68M |
Net Income | 282.81M |
EBITDA | 382.14M |
EBIT | 336.17M |
Earnings Per Share (EPS) | $8.88 |
Balance Sheet
The company has $245.45 million in cash and $142.12 million in debt, giving a net cash position of $103.33 million or $3.36 per share.
Cash & Cash Equivalents | 245.45M |
Total Debt | 142.12M |
Net Cash | 103.33M |
Net Cash Per Share | $3.36 |
Equity / Book Value | 558.95M |
Book Value Per Share | 18.17 |
Working Capital | -331.30M |
Cash Flow
In the last 12 months, operating cash flow was $433.37 million and capital expenditures -$36.65 million, giving a free cash flow of $396.73 million.
Operating Cash Flow | 433.37M |
Capital Expenditures | -36.65M |
Free Cash Flow | 396.73M |
FCF Per Share | $12.91 |
Margins
Gross margin is 27.81%, with operating and profit margins of 17.86% and 15.00%.
Gross Margin | 27.81% |
Operating Margin | 17.86% |
Pretax Margin | 17.80% |
Profit Margin | 15.00% |
EBITDA Margin | 20.26% |
EBIT Margin | 17.83% |
FCF Margin | 21.04% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 5.43% |
Shareholder Yield | 5.43% |
Earnings Yield | 2.27% |
FCF Yield | 3.18% |
Analyst Forecast
The average price target for MEDP is $389.00, which is -3.75% lower than the current price. The consensus rating is "Strong Buy".
Price Target | $389.00 |
Price Target Difference | -3.75% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 13.26% |
EPS Growth Forecast (5Y) | 14.70% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 8.2 and a Piotroski F-Score of 7.
Altman Z-Score | 8.2 |
Piotroski F-Score | 7 |